United States infectious disease
biomarker testing market is expected to witness double digit CAGR during the
forecast period. Key factors propelling the growth of United States infectious
disease biomarker testing market include growing demand for novel molecular
diagnostics testing tools due to increasing cases of coronavirus and presence
of leading market players in the country. Furthermore, frequent outbreak
of various infectious diseases is also acting as a major growth driver for this
market. The presence of highly developed healthcare system coupled with increasing
fund by government for R&D activities in biomarker testing is augmenting
the growth of United States infectious disease biomarker testing market.
Additionally, advancements in molecular techniques and growth in the
biomarker identification market are also expected to drive the United States infectious
disease biomarker testing market through 2027.
United States infectious disease
biomarker testing market can be categorized based on product, application, technology,
pathogen, end user and region. Based on technology, the market can be segmented
into PCR, NGS, ELISA or EIA, IHC, ISH and others. Among these, PCR dominated
the market in 2021 due to high popularity and adoption of PCR based products
compared to other technologies. However, NGS technology is expected to witness fastest
growth during the forecast period owing to the decreasing prices of NGS-based
tests.
Based on end user, United States
infectious disease biomarker testing market can be segmented into hospitals and
clinics, diagnostic centers, research laboratories and others. Among them, hospitals
and clinics segment are anticipated to undergo high growth in terms of revenue
through 2027 as they have laboratories equipped with fully automated diagnostic
instruments including NGS and PCR for providing better medical diagnostic
results.
Major players operating in the United
States infectious disease biomarker testing market include Abbott Laboratories,
Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad
Laboratories, Inc., Danaher Corporation, Hologic, Inc., PerkinElmer, Inc.,
Thermo Fisher Scientific, Inc., Hoffmann-La Roche Inc., Quest Diagnostics
Incorporated and Qiagen Sciences, Inc., among others. The market players are undergoing
partnerships and alliances to strengthen their business position in United
States.
Objective of the Study:
- To analyze and estimate the market size of United
States infectious disease biomarker testing market from 2017 to 2020.
- To estimate and forecast the market size of United
States infectious disease biomarker testing market from 2021 to 2027 and
growth rate until 2027.
- to classify and forecast United States infectious
disease biomarker testing market based on product, application, technology, pathogen, end user, company and regional
distribution.
- To identify dominant region or segment in the United
States infectious disease biomarker testing market.
- To identify drivers and challenges for United
States infectious disease biomarker testing market.
- To examine competitive developments such as
expansions, mergers & acquisitions, etc., in United States infectious
disease biomarker testing market.
- To conduct pricing analysis for United States infectious
disease biomarker testing market.
- To identify and analyze the profile of leading
players operating in United States infectious disease biomarker testing market.
- To identify key sustainable strategies adopted
by market players in United States infectious disease biomarker testing market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of infectious disease biomarker testing system manufacturers across
United States. Subsequently, TechSci Research conducted primary research
surveys with the identified companies. While interviewing, the respondents were
also enquired about their competitors. Through this technique, TechSci Research
could include the manufacturers who could not be identified due to the
limitations of secondary research. TechSci Research analyzed the presence of all
major players across United States.
TechSci Research calculated the market size of United States infectious disease
biomarker testing market using a bottom-up approach, wherein data for various
end-user segments was recorded and forecast for the future years. TechSci
Research sourced these values from the industry experts and company
representatives and externally validated through analyzing historical data of
these services and end users for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press
releases, company annual reports, investor presentations and financial reports
were also studied by TechSci Research.
Key Target Audience:
- Infectious disease biomarker
testing system manufacturers, suppliers, distributors and other
stakeholders
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to infectious disease biomarker testing
- Market research and
consulting firms
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as infectious disease biomarker testing system manufacturers, suppliers, partners,
end users, etc., besides allowing them in strategizing investments and
capitalizing on market opportunities.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Years
|
2017 – 2020
|
|
Estimated Year
|
2022E
|
|
Forecast Period
|
2023F – 2027F
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F
|
|
Report Coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
·
Product
·
Application
·
Technology
·
Pathogen
·
End User
|
|
Region Scope
|
South-Region, West-Region, Mid-West Region & Northeast-Region
|
|
Key Companies Profiled
|
Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton,
Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation,
Hologic, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Hoffmann-La
Roche Inc., Quest Diagnostics Incorporated and Qiagen Sciences, Inc.
|
|
Customization Scope
|
10% free report customization with purchase. Addition or
alteration to regional & segment scope.
|
|
Pricing and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase
options
|
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, United States infectious
disease biomarker testing market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- United States Infectious Disease Biomarker Testing
Market, By Product:
- United States Infectious Disease Biomarker Testing
Market, By Application:
- Respiratory Infection
- Sexually Transmitted Infection
- Bloodstream and Hospital-Acquired
Infection
- Urinary Tract Infection
- Gastro-Intestinal Infection
- Central Nervous System Infection
- Others
- United States Infectious Disease Biomarker Testing
Market, By Technology:
- PCR
- NGS
- ELISA or EIA
- IHC
- ISH
- Others
- United States Infectious Disease Biomarker Testing
Market, By Pathogen:
- Virus
- Influenza
- HIV-AIDS
- Hepatitis
- HPV
- Others
- Bacteria
- Tuberculosis
- CT/NG
- Hospital-Acquired Infection
- Others
- United States Infectious Disease Biomarker Testing
Market, By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research Laboratories
- Others
- United States Infectious Disease Biomarker Testing Market,
By Region:
- North-East
- Mid-West
- West
- South
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States infectious disease biomarker testing market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Profit Margin Analysis
- Profit margin analysis
in case of direct and indirect sales channel.
It is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]